BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 17239006)

  • 1. Abnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress.
    Woulfe JM
    Neuropathol Appl Neurobiol; 2007 Feb; 33(1):2-42. PubMed ID: 17239006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture.
    Pountney DL; Raftery MJ; Chegini F; Blumbergs PC; Gai WP
    Acta Neuropathol; 2008 Dec; 116(6):603-14. PubMed ID: 18836734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease.
    Sone J; Tanaka F; Koike H; Inukai A; Katsuno M; Yoshida M; Watanabe H; Sobue G
    Neurology; 2011 Apr; 76(16):1372-6. PubMed ID: 21411744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trinucleotide repeats and neurodegenerative disease.
    Everett CM; Wood NW
    Brain; 2004 Nov; 127(Pt 11):2385-405. PubMed ID: 15329351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of pathology-associated intranuclear inclusions.
    Iwahashi C; Hagerman PJ
    Methods Mol Biol; 2008; 463():181-90. PubMed ID: 18951169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranuclear inclusion bodies in an elderly demented woman: a form of intranuclear inclusion body disease.
    Weidenheim KM; Dickson DW
    Clin Neuropathol; 1995; 14(2):93-9. PubMed ID: 7606903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion-positive cell types in adult-onset intranuclear inclusion body disease: implications for clinical diagnosis.
    Liu Y; Mimuro M; Yoshida M; Hashizume Y; Niwa H; Miyao S; Ujihira N; Akatsu H
    Acta Neuropathol; 2008 Dec; 116(6):615-23. PubMed ID: 18923837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranuclear peudoinclusions: morphology, pathogenesis, and significance.
    Arora SK; Dey P
    Diagn Cytopathol; 2012 Aug; 40(8):741-4. PubMed ID: 21548120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of polyunsaturated fatty acids for misfolding protein aggregations: implication for neurodegenerative diseases.
    Kim YJ; Takahashi R
    Ann N Y Acad Sci; 2006 Nov; 1086():11-20. PubMed ID: 17185502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranuclear inclusions in epithelial cells of benign proliferative breast lesions.
    Harada O; Hoe R; Lin J; Thike AA; Jara-Lazaro AR; Petersson F; Tan PH
    J Clin Pathol; 2011 Sep; 64(9):776-80. PubMed ID: 21606232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valosin-containing protein immunoreactivity in tauopathies, synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease.
    Mori F; Tanji K; Toyoshima Y; Sasaki H; Yoshida M; Kakita A; Takahashi H; Wakabayashi K
    Neuropathology; 2013 Dec; 33(6):637-44. PubMed ID: 23782134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nature of the nuclear inclusions formed by PQBP1, a protein linked to neurodegenerative polyglutamine diseases.
    Nicolaescu E; Beullens M; Lesage B; Keppens S; Himpens B; Bollen M
    Eur J Cell Biol; 2008 Oct; 87(10):817-29. PubMed ID: 18599155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polyglutamine diseases: a pathologic view].
    Yamada M
    Rinsho Shinkeigaku; 2003 Nov; 43(11):903-5. PubMed ID: 15152499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations.
    Josephs KA; Ahmed Z; Katsuse O; Parisi JF; Boeve BF; Knopman DS; Petersen RC; Davies P; Duara R; Graff-Radford NR; Uitti RJ; Rademakers R; Adamson J; Baker M; Hutton ML; Dickson DW
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):142-51. PubMed ID: 17278999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear bodies in neurodegenerative disease.
    Woulfe J
    Biochim Biophys Acta; 2008 Nov; 1783(11):2195-206. PubMed ID: 18539152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influences of intranuclear inclusion on nuclear size - morphometric study on pontine neurons of neuronal intranuclear inclusion disease cases.
    Uchihara T; Tanaka J; Funata N; Arai K; Hattori T
    Acta Neuropathol; 2003 Feb; 105(2):103-8. PubMed ID: 12536220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuronal intranuclear hyaline inclusion disease (NIHID): an update].
    Takahashi-Fujigasaki J
    Brain Nerve; 2015 Feb; 67(2):199-204. PubMed ID: 25681365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders.
    Mori F; Nishie M; Piao YS; Kito K; Kamitani T; Takahashi H; Wakabayashi K
    Neuropathol Appl Neurobiol; 2005 Feb; 31(1):53-61. PubMed ID: 15634231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear compartmentalization and dynamics of the poly(A)-binding protein nuclear 1 (PABPN1) inclusions in supraoptic neurons under physiological and osmotic stress conditions.
    Villagra NT; Bengoechea R; VaquƩ JP; Llorca J; Berciano MT; Lafarga M
    Mol Cell Neurosci; 2008 Mar; 37(3):622-33. PubMed ID: 18255312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALS-associated protein FIG4 is localized in Pick and Lewy bodies, and also neuronal nuclear inclusions, in polyglutamine and intranuclear inclusion body diseases.
    Kon T; Mori F; Tanji K; Miki Y; Toyoshima Y; Yoshida M; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
    Neuropathology; 2014 Feb; 34(1):19-26. PubMed ID: 23888880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.